Sarah Gallois-Montbrun
Has grant
Research director (DR2)
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Characterization of the cellular network involved in HIV-1 alternative splicing during infection
Open Date: 2021-04-01
Close Date: 2024-03-01
Grant: Close
Exploring the dynamic regulation of HIV-1 transcriptome during infection
Open Date: 2021-01-01
Close Date: 2023-12-01
Grant: Close
Identification of SARS-CoV-2 RNA binding proteins during viral replication
Open Date: 2021-01-01
Close Date: 2021-12-01
Grant: Close
Identification des partenaires cellulaires de la protéine Vif du VIH-1:uORF, inhibition traductionnelle d'APOEBC3G par Vif et réplication virale
Open Date: 2020-10-01
Close Date: 2021-10-01
Grant: Close
Les transcrits antisens du VIH-1: de nouveaux acteurs de la latence?
Open Date: 2019-03-01
Close Date: 2020-02-01
Articles (8)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Bone marrow stromal antigen 2 (BST2)/tetherin is a restriction factor that reduces HIV-1 dissemination by tethering virus at the cell surface. BST2 also acts as a sensor of HIV-1 budding, establishing a cellular antiviral state. The HIV-1 Vpu protein antagonizes BST2 antiviral functions via multiple mechanisms, including the subversion of an LC3C-associated pathway, a key cell intrinsic antimicrobial mechanism. Here, we describe the first step of this viral-induced LC3C-associated process. This process is initiated at the plasma membrane through the recognition and internalization of virus-tethered BST2 by ATG5, an autophagy protein. ATG5 and BST2 assemble as a complex, independently of the viral protein Vpu and ahead of the recruitment of the ATG protein LC3C. The conjugation of ATG5 with ATG12 is dispensable for this interaction. ATG5 recognizes cysteine-linked homodimerized BST2 and specifically engages phosphorylated BST2 tethering viruses at the plasma membrane, in an LC3C-associated pathway. We also found that this LC3C-associated pathway is used by Vpu to attenuate the inflammatory responses mediated by virion retention. Overall, we highlight that by targeting BST2 tethering viruses, ATG5 acts as a signaling scaffold to trigger an LC3C-associated pathway induced by HIV-1 infection.
Year:
2023
Collaborators (6)
Laurent Softic
INSERM
Jean-Christophe Paillart
Research Director
CNRS Délégation Alsace
Sandrine Belouzard
Centre National de la Recherche Scientifique (CNRS)
Clarisse Berlioz-Torrent
Université Paris Cité
Mary ARNOULD
Lecturer (Maître de conférences)
University of Montpellier
Jean Dubuisson
Head of Laboratory
Institut Pasteur de Lille
Make your next move.
Prepare your application
Review drafts before you send them.